Tailoring cardiovascular risk assessment and prevention for women: One size does not fit all.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Disparities in Cardiovascular Disease in Women with Adverse Pregnancy Outcomes.medRxiv : the preprint server for health sciences · 2025
   Article
2. Trends in Mortality Due to Cardiovascular Diseases Among Patients With Parkinson's Disease in the United States: A Retrospective Analysis.Clinical cardiology · 2025
   Article
3. PREVENT Equation: The Black Sheep among Cardiovascular Risk Scores? A Comparative Agreement Analysis of Nine Prediction Models in High-Risk Lithuanian Women.Medicina (Kaunas, Lithuania) · 2024
   Article
4. Unique features of dyslipidemia in women across a lifetime and a tailored approach to management.American journal of preventive cardiology · 2024
   Review
5. Menopause Predisposes Women to Increased Risk of Cardiovascular Disease.Journal of clinical medicine · 2023
   Article
6. Percutaneous Coronary Interventions in Women.Current atherosclerosis reports · 2023
   Review
7. Abdominal obesity, serum estradiol and cardiovascular risk among Nigerian postmenopausal women: a cross-sectional study.African health sciences · 2023
   Article
8. Cardiovascular risk in menopausal women and our evolving understanding of menopausal hormone therapy: risks, benefits, and current guidelines for use.Therapeutic advances in endocrinology and metabolism · 2021
   Review
9. Associations Between Vascular Risk Across Adulthood and Brain Pathology in Late Life: Evidence From a British Birth Cohort.JAMA neurology · 2020
   Article
10. A review of maternal overweight and obesity and its impact on cardiometabolic outcomes during pregnancy and postpartum.Therapeutic advances in reproductive health
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.